KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Gross Margin (2016 - 2026)

Bio-Rad Laboratories has reported Gross Margin over the past 18 years, most recently at 52.25% for Q1 2026.

  • Quarterly Gross Margin fell 2.0% to 52.25% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 51.87% through Mar 2026, down 161.0% year-over-year, with the annual reading at 51.87% for FY2025, 186.0% down from the prior year.
  • Gross Margin was 52.25% for Q1 2026 at Bio-Rad Laboratories, up from 49.8% in the prior quarter.
  • Over five years, Gross Margin peaked at 57.51% in Q1 2022 and troughed at 49.8% in Q4 2025.
  • The 5-year median for Gross Margin is 53.36% (2024), against an average of 53.67%.
  • Year-over-year, Gross Margin soared 240bps in 2022 and then tumbled -396bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 54.37% in 2022, then fell by -1bps to 53.77% in 2023, then dropped by -5bps to 51.24% in 2024, then fell by -3bps to 49.8% in 2025, then grew by 5bps to 52.25% in 2026.
  • Per Business Quant, the three most recent readings for BIO's Gross Margin are 52.25% (Q1 2026), 49.8% (Q4 2025), and 52.59% (Q3 2025).